Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Resistance Assay
Synonyms |
|
||||||||||||||||
Cerner Name |
Hepatitis C Virus (HCV) Genotype 3 NS5A Drug Resistance Assay |
||||||||||||||||
Clinical Info |
Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. Assay should be used for patients with documented HCV genotype 3. |
||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||
Specimen Types |
Blood |
||||||||||||||||
Specimen Volume |
2.0 mL plasma from Lav top tube (1.0 mL Minimum volume) |
||||||||||||||||
Container |
Lavender Top Tube |
||||||||||||||||
Collection Instructions |
Collect specimen in lavender-top (EDTA) tubes. Do not use green-top (heparin) tubes. |
||||||||||||||||
Transport Instructions |
Frozen |
||||||||||||||||
Specimen Stability |
|||||||||||||||||
Methodology |
Polymerase chain reaction (PCR) amplification and DNA next generation sequencing (NGS) |
||||||||||||||||
Days Performed |
TAT: 11-15 Days |
||||||||||||||||
Performing Laboratories |
|
||||||||||||||||
CPT |
87900,87902 |
||||||||||||||||
PDM |
255666 |
||||||||||||||||
Results |
|
||||||||||||||||
Result InterpretationSpecial Instructions Limitations |
|||||||||||||||||
Forms |
|
||||||||||||||||